IL108194A - b, d, 6, 8-TETRAHYDROXY-2- METHYL- HEXAHYDRONAPHTHALENE-1- HEPTANOIC ACID, 8-ESTER DERIVATIVES OF d-LACTONES THEREOF, AND PHARMACEUTICAL COMPOSITIONS CONTAINING THE SAME - Google Patents
b, d, 6, 8-TETRAHYDROXY-2- METHYL- HEXAHYDRONAPHTHALENE-1- HEPTANOIC ACID, 8-ESTER DERIVATIVES OF d-LACTONES THEREOF, AND PHARMACEUTICAL COMPOSITIONS CONTAINING THE SAMEInfo
- Publication number
- IL108194A IL108194A IL108194A IL10819493A IL108194A IL 108194 A IL108194 A IL 108194A IL 108194 A IL108194 A IL 108194A IL 10819493 A IL10819493 A IL 10819493A IL 108194 A IL108194 A IL 108194A
- Authority
- IL
- Israel
- Prior art keywords
- methyl
- group
- compound
- acid
- hydroxy
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C69/00—Esters of carboxylic acids; Esters of carbonic or haloformic acids
- C07C69/02—Esters of acyclic saturated monocarboxylic acids having the carboxyl group bound to an acyclic carbon atom or to hydrogen
- C07C69/22—Esters of acyclic saturated monocarboxylic acids having the carboxyl group bound to an acyclic carbon atom or to hydrogen having three or more carbon atoms in the acid moiety
- C07C69/33—Esters of acyclic saturated monocarboxylic acids having the carboxyl group bound to an acyclic carbon atom or to hydrogen having three or more carbon atoms in the acid moiety esterified with hydroxy compounds having more than three hydroxy groups
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/21—Esters, e.g. nitroglycerine, selenocyanates
- A61K31/215—Esters, e.g. nitroglycerine, selenocyanates of carboxylic acids
- A61K31/22—Esters, e.g. nitroglycerine, selenocyanates of carboxylic acids of acyclic acids, e.g. pravastatin
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/335—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin
- A61K31/35—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin having six-membered rings with one oxygen as the only ring hetero atom
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
- A61P3/06—Antihyperlipidemics
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C69/00—Esters of carboxylic acids; Esters of carbonic or haloformic acids
- C07C69/66—Esters of carboxylic acids having esterified carboxylic groups bound to acyclic carbon atoms and having any of the groups OH, O—metal, —CHO, keto, ether, acyloxy, groups, groups, or in the acid moiety
- C07C69/67—Esters of carboxylic acids having esterified carboxylic groups bound to acyclic carbon atoms and having any of the groups OH, O—metal, —CHO, keto, ether, acyloxy, groups, groups, or in the acid moiety of saturated acids
- C07C69/675—Esters of carboxylic acids having esterified carboxylic groups bound to acyclic carbon atoms and having any of the groups OH, O—metal, —CHO, keto, ether, acyloxy, groups, groups, or in the acid moiety of saturated acids of saturated hydroxy-carboxylic acids
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C69/00—Esters of carboxylic acids; Esters of carbonic or haloformic acids
- C07C69/66—Esters of carboxylic acids having esterified carboxylic groups bound to acyclic carbon atoms and having any of the groups OH, O—metal, —CHO, keto, ether, acyloxy, groups, groups, or in the acid moiety
- C07C69/73—Esters of carboxylic acids having esterified carboxylic groups bound to acyclic carbon atoms and having any of the groups OH, O—metal, —CHO, keto, ether, acyloxy, groups, groups, or in the acid moiety of unsaturated acids
- C07C69/732—Esters of carboxylic acids having esterified carboxylic groups bound to acyclic carbon atoms and having any of the groups OH, O—metal, —CHO, keto, ether, acyloxy, groups, groups, or in the acid moiety of unsaturated acids of unsaturated hydroxy carboxylic acids
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D309/00—Heterocyclic compounds containing six-membered rings having one oxygen atom as the only ring hetero atom, not condensed with other rings
- C07D309/16—Heterocyclic compounds containing six-membered rings having one oxygen atom as the only ring hetero atom, not condensed with other rings having one double bond between ring members or between a ring member and a non-ring member
- C07D309/28—Heterocyclic compounds containing six-membered rings having one oxygen atom as the only ring hetero atom, not condensed with other rings having one double bond between ring members or between a ring member and a non-ring member with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
- C07D309/30—Oxygen atoms, e.g. delta-lactones
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N9/00—Enzymes; Proenzymes; Compositions thereof; Processes for preparing, activating, inhibiting, separating or purifying enzymes
- C12N9/0004—Oxidoreductases (1.)
- C12N9/0093—Oxidoreductases (1.) acting on CH or CH2 groups (1.17)
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12P—FERMENTATION OR ENZYME-USING PROCESSES TO SYNTHESISE A DESIRED CHEMICAL COMPOUND OR COMPOSITION OR TO SEPARATE OPTICAL ISOMERS FROM A RACEMIC MIXTURE
- C12P17/00—Preparation of heterocyclic carbon compounds with only O, N, S, Se or Te as ring hetero atoms
- C12P17/02—Oxygen as only ring hetero atoms
- C12P17/06—Oxygen as only ring hetero atoms containing a six-membered hetero ring, e.g. fluorescein
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12P—FERMENTATION OR ENZYME-USING PROCESSES TO SYNTHESISE A DESIRED CHEMICAL COMPOUND OR COMPOSITION OR TO SEPARATE OPTICAL ISOMERS FROM A RACEMIC MIXTURE
- C12P7/00—Preparation of oxygen-containing organic compounds
- C12P7/62—Carboxylic acid esters
-
- Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
- Y02—TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
- Y02P—CLIMATE CHANGE MITIGATION TECHNOLOGIES IN THE PRODUCTION OR PROCESSING OF GOODS
- Y02P20/00—Technologies relating to chemical industry
- Y02P20/50—Improvements relating to the production of bulk chemicals
- Y02P20/55—Design of synthesis routes, e.g. reducing the use of auxiliary or protecting groups
Landscapes
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Engineering & Computer Science (AREA)
- Wood Science & Technology (AREA)
- Zoology (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Genetics & Genomics (AREA)
- General Health & Medical Sciences (AREA)
- Biotechnology (AREA)
- Microbiology (AREA)
- Biochemistry (AREA)
- General Engineering & Computer Science (AREA)
- General Chemical & Material Sciences (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Medicinal Chemistry (AREA)
- Biomedical Technology (AREA)
- Animal Behavior & Ethology (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- Molecular Biology (AREA)
- Pharmacology & Pharmacy (AREA)
- Epidemiology (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Obesity (AREA)
- Hematology (AREA)
- Emergency Medicine (AREA)
- Diabetes (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
- Preparation Of Compounds By Using Micro-Organisms (AREA)
- Pyrane Compounds (AREA)
- Indole Compounds (AREA)
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| JP34903492 | 1992-12-28 |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| IL108194A0 IL108194A0 (en) | 1994-04-12 |
| IL108194A true IL108194A (en) | 1998-02-22 |
Family
ID=18401049
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| IL108194A IL108194A (en) | 1992-12-28 | 1993-12-27 | b, d, 6, 8-TETRAHYDROXY-2- METHYL- HEXAHYDRONAPHTHALENE-1- HEPTANOIC ACID, 8-ESTER DERIVATIVES OF d-LACTONES THEREOF, AND PHARMACEUTICAL COMPOSITIONS CONTAINING THE SAME |
Country Status (23)
| Country | Link |
|---|---|
| US (2) | US5451688A (de) |
| EP (1) | EP0605230B1 (de) |
| JP (1) | JPH06247894A (de) |
| KR (1) | KR100286596B1 (de) |
| CN (1) | CN1039642C (de) |
| AT (1) | ATE157346T1 (de) |
| AU (1) | AU670468B2 (de) |
| CA (1) | CA2112442A1 (de) |
| CZ (1) | CZ280492B6 (de) |
| DE (1) | DE69313427T2 (de) |
| DK (1) | DK0605230T3 (de) |
| ES (1) | ES2108238T3 (de) |
| FI (1) | FI935895A7 (de) |
| GR (1) | GR3025412T3 (de) |
| HK (1) | HK1000937A1 (de) |
| HU (1) | HU221845B1 (de) |
| IL (1) | IL108194A (de) |
| MX (1) | MX9400060A (de) |
| NO (1) | NO300730B1 (de) |
| NZ (1) | NZ250609A (de) |
| RU (1) | RU2104997C1 (de) |
| TW (1) | TW289753B (de) |
| ZA (1) | ZA939741B (de) |
Families Citing this family (34)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| JPH0251582A (ja) * | 1988-08-12 | 1990-02-21 | Kyokado Eng Co Ltd | 地盤注入用薬液 |
| US5989877A (en) * | 1995-08-03 | 1999-11-23 | Gist-Brocades B.V. | Selective process for the deacylation of acylated compounds |
| KR100186758B1 (ko) * | 1996-08-09 | 1999-04-01 | 영진약품공업 주식회사 | 프라바스타틴(pravastatin)전구체의제조방법 |
| CA2226996C (en) * | 1997-01-24 | 2006-08-15 | Kose Corporation | Whitening cosmetic composition comprising polyhydric alcohol |
| ES2306482T3 (es) * | 1997-08-28 | 2008-11-01 | Novartis Ag | Antagonistas de antigeno-1 funcion con funcion de linfocito. |
| DE19848597C2 (de) * | 1998-04-16 | 2000-04-20 | Georg Dietz | Zubereitung aus Calciumhydroxid, einem zwei- oder mehrwertigen Alkohol und einem fetten Öl vegetarischen oder animalischen Ursprungs und seine Verwendung zur Kollagenneubildung |
| SI20305A (sl) * | 1999-08-06 | 2001-02-28 | LEK, tovarna farmacevtskih in kemi�nih izdelkov, d.d. | Kristali natrijeve soli pravastatina |
| US6682913B1 (en) | 1999-02-03 | 2004-01-27 | Institute For Drug Research Ltd. | Microbial process for preparing pravastatin |
| CO5140104A1 (es) * | 1999-02-16 | 2002-03-22 | Novartis Ag | Derivados de mevinolina y preparacion farmaceuticas que los contienen |
| DE69932746D1 (de) * | 1999-03-08 | 2006-09-21 | Kitasato Inst | SUBSTANZEN WK-5344A UND Wk-5344B UND VERFAHREN ZUR HERSTELLUNG DERSELBEN |
| HUP9902352A1 (hu) * | 1999-07-12 | 2000-09-28 | Gyógyszerkutató Intézet Kft. | Eljárás pravasztatin mikrobiológiai előállítására |
| JP3881240B2 (ja) * | 1999-11-30 | 2007-02-14 | テバ ジョジセルジャール ザ−トケルエン ムケド レ−スベニュタ−ルシャシャ−グ | 醗酵ブロスからスタチン化合物を回収するための方法 |
| SK8312002A3 (en) | 1999-12-14 | 2003-05-02 | Biogal Gyogyszergyar | Novel forms of pravastatin sodium |
| CN1468098A (zh) * | 2000-10-05 | 2004-01-14 | �ݰ¸Ƕ�ҩ������˾ | 基本上无普伐他汀内酯和表普伐他汀的普伐他汀钠和包含普伐他汀钠的组合物 |
| JP2002121172A (ja) * | 2000-10-16 | 2002-04-23 | Sankyo Co Ltd | プラバスタチン又はその薬理上許容される塩の精製方法 |
| JP3236282B1 (ja) * | 2000-10-16 | 2001-12-10 | 三共株式会社 | プラバスタチンを精製する方法 |
| KR100458151B1 (ko) * | 2001-05-14 | 2004-11-26 | 씨제이 주식회사 | 프락토실 트랜스퍼라제를 생산하는 신규 미생물 및 이를이용하여 프락토올리고당 및 네오프락토올리고당을생산하는 방법 |
| RU2206330C1 (ru) * | 2002-05-30 | 2003-06-20 | Кулемин Леонид Михайлович | Средство, обладающее иммуномодулирующей, энтеросорбционной, антитоксической и противовоспалительной активностью и способ его получения |
| US7071197B2 (en) | 2002-06-14 | 2006-07-04 | Recordati S.A. | N,N-disubstituted diazocycloalkanes |
| ITMI20021327A1 (it) * | 2002-06-14 | 2003-12-15 | Recordati Chem Pharm | Nuove ossialchilpiperazine |
| US7029178B2 (en) * | 2002-10-04 | 2006-04-18 | Ght Ventures, Llc | Zip-lock closure |
| CA2546377A1 (en) | 2003-11-24 | 2005-06-09 | Teva Gyogyszergyar Zartkoruen Mukodo Reszvenytarsasag | Method of purifying pravastatin |
| US20070185193A1 (en) * | 2003-12-01 | 2007-08-09 | Huaibei Huike Pharmaceutical, Co. Ltd. | Huvastatin and its preparation and formulation comprising the huvastatin |
| CN1277826C (zh) * | 2003-12-01 | 2006-10-04 | 叶红平 | 辉伐他汀及其合成方法和以辉伐他汀为原料药的制剂 |
| WO2005121062A2 (en) * | 2004-06-09 | 2005-12-22 | Ranbaxy Laboratories Limited | Process for the preparation of pravastatin |
| US7714017B2 (en) * | 2004-10-12 | 2010-05-11 | Decode Genetics, Ehf | Carboxylic acid peri-substituted bicyclics for occlusive artery disease |
| TWI307360B (en) | 2004-12-03 | 2009-03-11 | Teva Gyogyszergyar Zartkoruen Mukodo Reszvenytarsasag | Process for constructing strain having compactin hydroxylation ability |
| US20090068325A1 (en) * | 2007-09-10 | 2009-03-12 | Gil Depicciotto | Method of treatment of fresh produce |
| EP2241561A1 (de) * | 2009-04-16 | 2010-10-20 | Neuron Biopharma, S.A. | Neuroprotektive, hypercholesterolemische und antiepileptische Verbindung |
| ES2380473B1 (es) * | 2010-10-13 | 2013-02-19 | Neuron Biopharma, S.A. | Compuesto neuroprotector, hipocolesterolémico, antiinflamatorio y antiepiléptico. |
| WO2014148455A1 (ja) * | 2013-03-19 | 2014-09-25 | 第一三共株式会社 | テルペノイド誘導体 |
| CN108546721B (zh) * | 2018-04-20 | 2021-04-13 | 安徽大学 | 一种利用微生物合成对羟基苯甲酸的方法 |
| EP4284353A4 (de) * | 2021-02-01 | 2025-10-22 | Univ Toledo | C prime-mittel zur behandlung von stoffwechselerkrankungen |
| CN114250254B (zh) * | 2021-12-20 | 2024-01-05 | 宁夏清研高分子新材料有限公司 | 一种对羟基苯甲酸的微生物合成方法 |
Family Cites Families (15)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CH381478A (de) * | 1959-11-21 | 1964-08-31 | Atkinsons Agricultural Appl | Sicherheitsschutzvorrichtung für Gelenkwellenkupplungen |
| US4137322A (en) * | 1976-11-02 | 1979-01-30 | Sankyo Company Limited | ML-236B carboxylic acid derivatives and their use as antihyperlipemic agents |
| AU548996B2 (en) * | 1980-02-04 | 1986-01-09 | Merck & Co., Inc. | Tetrahydro-2h-pyran-2-one derivatives |
| MX7065E (es) * | 1980-06-06 | 1987-04-10 | Sankyo Co | Un procedimiento microbiologico para preparar derivados de ml-236b |
| JPS5810572A (ja) * | 1981-07-07 | 1983-01-21 | Sankyo Co Ltd | Ml−236b誘導体およびその製造法 |
| JPS5889191A (ja) * | 1981-11-20 | 1983-05-27 | Sankyo Co Ltd | 3−ヒドロキシ−ml−236b誘導体の製造法 |
| JPS5917545A (ja) * | 1982-07-22 | 1984-01-28 | Canon Inc | オ−トフオ−カスカメラの距離表示機構 |
| JPS59175450A (ja) * | 1983-03-24 | 1984-10-04 | Sankyo Co Ltd | Ml−236b誘導体 |
| US4997848A (en) * | 1987-10-27 | 1991-03-05 | Sankyo Company, Limited | Octahydronaphthalene oxime derivatives for cholesterol synthesis inhibition |
| US5049696A (en) * | 1988-04-11 | 1991-09-17 | Merck & Co., Inc. | Antihypercholesterolemic compounds |
| CA2009043A1 (en) * | 1989-02-01 | 1990-08-01 | Michael J. Ferris | Process for the preparation of 6-alpha-hydroxymethyl lovastatin derivatives |
| GB8915280D0 (en) * | 1989-07-04 | 1989-08-23 | British Bio Technology | Compounds |
| GB9007738D0 (en) * | 1990-04-05 | 1990-06-06 | British Bio Technology | Compounds |
| GB9100174D0 (en) * | 1991-01-04 | 1991-02-20 | British Bio Technology | Compounds |
| IL108432A (en) * | 1993-01-29 | 1997-09-30 | Sankyo Co | DERIVATIVES OF 3, 5-DIHYDROXY-7- £1, 2, 6, 7, 8, 8a-HEXAHYDRO-2- METHYL-8- (SUBSTITUTED ALKANOYLOXY)-1-NAPHTHYL| HEPTANOIC ACID AND THEIR LACTONES, THEIR PREPARATION, AND PHARMACEUTICAL COMPOSITIONS CONTAINING THEM |
-
1993
- 1993-12-23 NZ NZ250609A patent/NZ250609A/xx unknown
- 1993-12-24 AU AU52699/93A patent/AU670468B2/en not_active Ceased
- 1993-12-24 AT AT93310536T patent/ATE157346T1/de not_active IP Right Cessation
- 1993-12-24 ES ES93310536T patent/ES2108238T3/es not_active Expired - Lifetime
- 1993-12-24 DK DK93310536.3T patent/DK0605230T3/da active
- 1993-12-24 EP EP93310536A patent/EP0605230B1/de not_active Expired - Lifetime
- 1993-12-24 DE DE69313427T patent/DE69313427T2/de not_active Expired - Fee Related
- 1993-12-24 CA CA002112442A patent/CA2112442A1/en not_active Abandoned
- 1993-12-27 CZ CZ932900A patent/CZ280492B6/cs unknown
- 1993-12-27 NO NO934852A patent/NO300730B1/no unknown
- 1993-12-27 HU HU9303762A patent/HU221845B1/hu not_active IP Right Cessation
- 1993-12-27 TW TW082111024A patent/TW289753B/zh active
- 1993-12-27 RU RU93056837A patent/RU2104997C1/ru not_active IP Right Cessation
- 1993-12-27 IL IL108194A patent/IL108194A/en active IP Right Grant
- 1993-12-28 FI FI935895A patent/FI935895A7/fi unknown
- 1993-12-28 KR KR1019930030497A patent/KR100286596B1/ko not_active Expired - Fee Related
- 1993-12-28 US US08/174,661 patent/US5451688A/en not_active Expired - Fee Related
- 1993-12-28 ZA ZA939741A patent/ZA939741B/xx unknown
- 1993-12-28 CN CN93121768A patent/CN1039642C/zh not_active Expired - Fee Related
- 1993-12-28 JP JP5335405A patent/JPH06247894A/ja active Pending
-
1994
- 1994-01-03 MX MX9400060A patent/MX9400060A/es not_active IP Right Cessation
-
1995
- 1995-12-28 US US08/579,840 patent/US5827855A/en not_active Expired - Fee Related
-
1997
- 1997-11-19 GR GR970403057T patent/GR3025412T3/el unknown
- 1997-12-23 HK HK97102563A patent/HK1000937A1/en not_active IP Right Cessation
Also Published As
| Publication number | Publication date |
|---|---|
| JPH06247894A (ja) | 1994-09-06 |
| NZ250609A (en) | 1995-07-26 |
| MX9400060A (es) | 1994-07-29 |
| EP0605230B1 (de) | 1997-08-27 |
| ES2108238T3 (es) | 1997-12-16 |
| HU221845B1 (hu) | 2003-02-28 |
| DK0605230T3 (da) | 1998-04-20 |
| IL108194A0 (en) | 1994-04-12 |
| ATE157346T1 (de) | 1997-09-15 |
| RU2104997C1 (ru) | 1998-02-20 |
| NO934852L (no) | 1994-06-29 |
| FI935895A7 (fi) | 1994-10-19 |
| CZ290093A3 (en) | 1994-08-17 |
| AU5269993A (en) | 1994-07-07 |
| DE69313427D1 (de) | 1997-10-02 |
| HUT65593A (en) | 1994-07-28 |
| CA2112442A1 (en) | 1994-06-29 |
| NO934852D0 (no) | 1993-12-27 |
| NO300730B1 (no) | 1997-07-14 |
| CN1039642C (zh) | 1998-09-02 |
| HU9303762D0 (en) | 1994-04-28 |
| KR100286596B1 (ko) | 2001-04-16 |
| ZA939741B (en) | 1994-08-15 |
| US5827855A (en) | 1998-10-27 |
| DE69313427T2 (de) | 1998-03-26 |
| KR940014294A (ko) | 1994-07-18 |
| HK1000937A1 (en) | 1998-05-08 |
| FI935895A0 (fi) | 1993-12-28 |
| TW289753B (de) | 1996-11-01 |
| CN1094707A (zh) | 1994-11-09 |
| AU670468B2 (en) | 1996-07-18 |
| EP0605230A1 (de) | 1994-07-06 |
| US5451688A (en) | 1995-09-19 |
| CZ280492B6 (cs) | 1996-01-17 |
| GR3025412T3 (en) | 1998-02-27 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| US5451688A (en) | Hexahydronaphthalene ester derivatives, their preparation and their therapeutic uses | |
| HK1000937B (en) | Hexahydronaphthalene ester derivatives, their preparation and their therapeutic uses | |
| AU2006203704B8 (en) | Percyquinnin | |
| US4294846A (en) | Hypocholesteremic fermentation products and products of preparation | |
| JP4795931B2 (ja) | 置換複素環 | |
| JPH0371419B2 (de) | ||
| US4420491A (en) | Hypocholesteremic fermentation products and process of preparation | |
| KR100293335B1 (ko) | 헥사히드로나프탈렌에스테르유도체.그의제조방법및그의치료적용도 | |
| US5294609A (en) | DNA gyrase inhibitors and pharmaceutical preparations therefor | |
| KR920009527B1 (ko) | 신규의 테트라사이클로 화합물의 제조방법 | |
| FI75186B (fi) | Foerfarande foer framstaellning av ml-236b-derivat. | |
| RU2125043C1 (ru) | Производные октагидронафталиноксима, фармацевтическая композиция, способ лечения и способ их получения | |
| SK11202003A3 (sk) | Použitie tiolutín-dioxidu a jeho derivátov na prípravu liečiva, spôsob jeho prípravy pomocou mikroorganizmu a mikroorganizmus Nocardiopsis species ST 100692, DSM 13834 | |
| WO1999060151A1 (en) | New biotechnological process for preparing hydroxylated ml-236b derivatives, known as m-4 and m-4', and analogues thereof |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| FF | Patent granted | ||
| KB | Patent renewed | ||
| KB | Patent renewed |